Cherrington Julie M 4
4 · Mirati Therapeutics, Inc. · Filed Jan 20, 2023
Insider Transaction Report
Form 4
Cherrington Julie M
Director
Transactions
- Sale
Common Stock
2023-01-18$44.66/sh−2,546$113,704→ 0 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2021.